Eugenia Njolito

Title: Inventor Spotlight: Eugenia Njolito

Introduction

Eugenia Njolito is a prominent inventor based in Princeton, NJ, who has made significant contributions to the field of organic chemistry. With a keen focus on chiral compounds, she has developed innovative processes that enhance the preparation of biologically active molecules.

Latest Patents

Eugenia holds a patent for a process entitled "Process for the preparation of chiral beta amino acid derivatives by asymmetric hydrogenation." This invention enables the efficient preparation of enantiomerically enriched beta amino acid derivatives, playing a crucial role in the asymmetric synthesis of biologically active molecules. The process involves an enantioselective hydrogenation of a prochiral beta amino acrylic acid derivative substrate, utilizing a transition metal precursor complexed with a chiral ferrocenyl diphosphine ligand.

Career Highlights

Eugenia currently works at Merck & Company, Inc., a leading global health care company known for its research and development in pharmaceuticals and biologics. Her innovative work not only showcases her expertise but also reflects the commitment of Merck to advancing scientific knowledge and technology.

Collaborations

During her career, Eugenia has collaborated with talented colleagues, including Yi Xiao and Joseph D Armstrong, III. These partnerships have undoubtedly enriched her research, fostering an environment of collective innovation and discovery within the scientific community.

Conclusion

Eugenia Njolito's work stands as a testament to the power of innovation in chemistry, contributing essential knowledge for the development of therapeutics. Her achievements continue to inspire upcoming inventors and researchers aiming to make an impact in the pharmaceutical landscape and beyond.